Intellia Thera CS (NTLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NTLA | AZN | AMGN | GILD | BMY |
| Company | Intellia Thera CS | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 11.99 | 95.30 | 328.97 | 124.31 | 56.73 |
| High | 12.01 | 95.36 | 329.30 | 124.57 | 57.00 |
| Low | 11.34 | 93.41 | 325.19 | 123.12 | 55.34 |
| Latest | 11.62 | 93.95 | 327.77 | 123.48 | 55.85 |
| Change | -0.40 | -2.39 | -1.20 | -0.59 | -1.17 |
| % Change | -3.33% | -2.48% | -0.36% | -0.48% | -2.05% |
| Volume | 1,821,905 | 2,511,348 | 299,280 | 908,992 | 3,249,547 |
| 20-Day Average Volume | 4,227,156 | 5,056,895 | 2,556,040 | 5,977,673 | 13,935,278 |
| Previous Close | 12.02 | 96.34 | 328.97 | 124.07 | 57.02 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 9.91 | 92.89 | 328.71 | 122.84 | 54.77 |
| 20-Day Raw Stochastic | 73.47% | 62.32% | 30.77% | 61.56% | 72.09% |
| 20-Day Relative Strength | 55.54 | 56.41 | 49.83 | 51.71 | 61.10 |
| Weighted Alpha | +96.31 | +43.33 | +19.75 | +29.97 | +7.67 |
| Today's Opinion | 24% Sell | 100% Buy | 48% Buy | 72% Buy | 96% Buy |
| Previous Opinion | 8% Sell | 100% Buy | 64% Buy | 72% Buy | 88% Buy |
| Last Month's Opinion | 24% Sell | 100% Buy | 72% Buy | 56% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.22% since 01/08/26 | -0.14% since 01/08/26 | -1.29% since 01/08/26 | +2.23% since 01/08/26 | -0.45% since 01/08/26 |
| Low | 10.13 on 01/09/26 | 92.78 on 01/13/26 | 319.79 on 01/13/26 | 119.33 on 01/09/26 | 55.33 on 01/15/26 |
| High | 12.34 on 01/14/26 | 96.43 on 01/14/26 | 332.08 on 01/09/26 | 124.52 on 01/15/26 | 57.04 on 01/14/26 |
| 1-Month | |||||
| %Chg | +24.56% since 12/15/25 | +2.53% since 12/15/25 | +0.17% since 12/15/25 | +2.99% since 12/15/25 | +2.51% since 12/15/25 |
| Low | 8.74 on 12/18/25 | 89.53 on 01/05/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 52.06 on 01/05/26 |
| High | 12.34 on 01/14/26 | 96.51 on 01/07/26 | 343.05 on 01/07/26 | 127.41 on 12/23/25 | 57.04 on 01/14/26 |
| 3-Month | |||||
| %Chg | -56.09% since 10/15/25 | +10.67% since 10/15/25 | +9.60% since 10/15/25 | +4.28% since 10/15/25 | +27.61% since 10/15/25 |
| Low | 7.95 on 11/21/25 | 80.48 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 |
| High | 28.25 on 10/20/25 | 96.51 on 01/07/26 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 57.04 on 01/14/26 |
| 6-Month | |||||
| %Chg | -0.83% since 07/15/25 | +33.50% since 07/15/25 | +11.40% since 07/15/25 | +13.11% since 07/15/25 | +19.86% since 07/15/25 |
| Low | 7.95 on 11/21/25 | 68.61 on 07/21/25 | 269.77 on 09/26/25 | 107.75 on 07/21/25 | 42.52 on 10/29/25 |
| High | 28.25 on 10/20/25 | 96.51 on 01/07/26 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 57.04 on 01/14/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,392,277 | 298,793,856 | 177,144,096 | 153,931,168 | 116,078,640 |
| Shares Outstanding, K | 115,830 | 3,101,452 | 538,481 | 1,240,680 | 2,035,753 |
| Annual Sales | 57,880,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 48,300,000,000 |
| Annual Net Income | -519,020,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -8,948,000,000 |
| Last Quarter Sales | 13,780,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 12,222,000,000 |
| Last Quarter Net Income | -101,320,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 2,201,000,000 |
| 60-Month Beta | 2.05 | 0.34 | 0.45 | 0.33 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.92 on 11/06/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 1.63 on 10/30/25 |
| Latest Earnings Date | 02/26/26 | 02/10/26 | 02/03/26 | 02/10/26 | 02/05/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.68 | 14.83 | 14.87 | 8.52 |